Are you ready to explore the dynamic world of integrated evidence plans (IEPs) with me?
Have you ever wondered how pharmaceutical companies align their strategies across functions and geographies to support a product’s lifecycle?
In today's episode, I dive into the complexities and significance of IEPs. I’m excited to have the insightful Jenny Devenport with me, bringing her wealth of experience in medical affairs.
Together, we uncover what integrated evidence plans entail, why they are crucial for minimizing duplication of efforts, and how they cater to various stakeholders' needs. So, what exactly is an integrated evidence plan, and how can statisticians play a pivotal role in shaping them? Let's find out!
